series-b
Stage
1
Investors
About
StrandTx is a clinical-stage biotechnology company developing mRNA therapeutics targeting cancer and autoimmune diseases using proprietary lipid nanoparticle delivery and RNA engineering technologies.
Explore StrandTx's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.